Cargando…

5‐FU inhibits migration and invasion of CRC cells through PI3K/AKT pathway regulated by MARCH1

Colorectal cancer is a major health problem with a significant impact on the patients' quality of life. 5‐Fluorouracil is the most common chemotherapy drug used for this type of cancer. While its molecular mechanism is the inhibition of DNA synthesis via the inhibition of thymine nucleotide syn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Nuan, Yang, Lijuan, Dai, Juanjuan, Wu, Yan, Zhang, Ranran, Jia, Xingfang, Liu, Chengxia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894547/ https://www.ncbi.nlm.nih.gov/pubmed/33085122 http://dx.doi.org/10.1002/cbin.11493

Ejemplares similares

Actinomycin V Induces Apoptosis Associated with Mitochondrial and PI3K/AKT Pathways in Human CRC Cells
por: Jiang, Shiqing, et al.
Publicado: (2021)

Proteomic analysis of the chemosensitizing effect of curcumin on CRC cells treated with 5-FU
por: Yang, Jingbo, et al.
Publicado: (2022)

TIPE Regulates DcR3 Expression and Function by Activating the PI3K/AKT Signaling Pathway in CRC
por: Zhong, Mengya, et al.
Publicado: (2021)

NDRG4 sensitizes CRC cells to 5-FU by upregulating DDIT3 expression
por: Li, Ruikai, et al.
Publicado: (2021)

NDRG4 sensitizes CRC cells to 5-FU by upregulating DDIT3 expression
por: Li, Ruikai, et al.
Publicado: (2022)

Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway
por: Lin, Lin, et al.
Publicado: (2022)

Verbascoside: Identification, Quantification, and Potential Sensitization of Colorectal Cancer Cells to 5-FU by Targeting PI3K/AKT Pathway
por: Attia, Yasmeen M., et al.
Publicado: (2018)

Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway
por: Xu, Jun, et al.
Publicado: (2017)

NSC30049 inhibits Chk1 pathway in 5-FU-resistant CRC bulk and stem cell populations
por: Narayan, Satya, et al.
Publicado: (2017)

TIPE2 Overexpression Suppresses the Proliferation, Migration, and Invasion in Prostate Cancer Cells by Inhibiting PI3K/Akt Signaling Pathway
por: Lu, Qiang, et al.
Publicado: (2016)

CLCA4 inhibits bladder cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT pathway
por: Hou, Teng, et al.
Publicado: (2017)

Casticin inhibits breast cancer cell migration and invasion by down-regulation of PI3K/Akt signaling pathway
por: Fan, Li, et al.
Publicado: (2018)

Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway
por: Zhu, Biqiang, et al.
Publicado: (2019)

Fisetin inhibits the proliferation, migration and invasion of pancreatic cancer by targeting PI3K/AKT/mTOR signaling
por: Xiao, Yanyi, et al.
Publicado: (2021)

Sanguinarine inhibits melanoma invasion and migration by targeting the FAK/PI3K/AKT/mTOR signalling pathway
por: Qi, Xiaoyi, et al.
Publicado: (2023)

Artemisinin Inhibits the Migration and Invasion in Uveal Melanoma via Inhibition of the PI3K/AKT/mTOR Signaling Pathway
por: Farhan, Mohd, et al.
Publicado: (2021)

Girdin regulates the migration and invasion of glioma cells via the PI3K-Akt signaling pathway
por: NI, WEIMIN, et al.
Publicado: (2015)

A novel peptide promotes human trophoblast proliferation and migration through PI3K/Akt/mTOR signaling pathway
por: Ling, Li, et al.
Publicado: (2021)

miR-130b suppresses the invasion and migration of prostate cancer via inhibiting DLL1 and regulating the PI3K/Akt pathways
por: Jia, Li, et al.
Publicado: (2022)

Ginsenoside compound K inhibits the proliferation, migration and invasion of Eca109 cell via VEGF-A/Pi3k/Akt pathway
por: Huang, Jianhou, et al.
Publicado: (2022)

Ginsenoside Rg3 enhances the anticancer effect of 5-FU in colon cancer cells via the PI3K/AKT pathway
por: Hong, Shunzhong, et al.
Publicado: (2020)

Tanshinol inhibits the growth, migration and invasion of hepatocellular carcinoma cells via regulating the PI3K-AKT signaling pathway
por: Zhu, Pingting, et al.
Publicado: (2018)

Correction: CLCA4 inhibits bladder cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT pathway
por: Hou, Teng, et al.
Publicado: (2019)

DOK7 Inhibits Cell Proliferation, Migration, and Invasion of Breast Cancer via the PI3K/PTEN/AKT Pathway
por: Yue, Changli, et al.
Publicado: (2021)

Expression of Concern: Casticin inhibits breast cancer cell migration and invasion by downregulation of PI3K/Akt signaling pathway
Publicado: (2021)

Knockdown of UBE2T Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion by Suppressing the PI3K/Akt Signaling Pathway
por: Wang, Yu, et al.
Publicado: (2016)

CEP55 promotes the proliferation, migration and invasion of esophageal squamous cell carcinoma via the PI3K/Akt pathway
por: Jia, Yang, et al.
Publicado: (2018)

PGM1 suppresses colorectal cancer cell migration and invasion by regulating the PI3K/AKT pathway
por: Zheng, Zhewen, et al.
Publicado: (2022)

Shen-Fu Injection Preconditioning Inhibits Myocardial Ischemia-Reperfusion Injury in Diabetic Rats: Activation of eNOS via the PI3K/Akt Pathway
por: Wu, Yang, et al.
Publicado: (2011)

MiR-499a-5p promotes 5-FU resistance and the cell proliferation and migration through activating PI3K/Akt signaling by targeting PTEN in pancreatic cancer
por: Ouyang, Liu, et al.
Publicado: (2021)

MARCH1 encourages tumour progression of hepatocellular carcinoma via regulation of PI3K‐AKT‐β‐catenin pathways
por: Xie, Lulu, et al.
Publicado: (2019)

Author Correction: Verbascoside: Identification, Quantification, and Potential Sensitization of Colorectal Cancer Cells to 5-FU by Targeting PI3K/AKT Pathway
por: Attia, Yasmeen M., et al.
Publicado: (2019)

PENK inhibits osteosarcoma cell migration by activating the PI3K/Akt signaling pathway
por: Zhang, Hai-ping, et al.
Publicado: (2020)

MKRN2 inhibits migration and invasion of non-small-cell lung cancer by negatively regulating the PI3K/Akt pathway
por: Jiang, Jun, et al.
Publicado: (2018)

Suppression of STIM1 inhibits the migration and invasion of human prostate cancer cells and is associated with PI3K/Akt signaling inactivation
por: Zhou, Yibin, et al.
Publicado: (2017)

GPER1 Silencing Suppresses the Proliferation, Migration, and Invasion of Gastric Cancer Cells by Inhibiting PI3K/AKT–Mediated EMT
por: Xu, En, et al.
Publicado: (2020)

Knockdown of Annexin-A1 Inhibits Growth, Migration and Invasion of Glioma Cells by Suppressing the PI3K/Akt Signaling Pathway
por: Wei, Liqing, et al.
Publicado: (2021)

Apatinib inhibits pancreatic cancer growth, migration and invasion through the PI3K/AKT and ERK1/2/MAPK pathways
por: Hu, Yuan, et al.
Publicado: (2021)

VEGFA Upregulates FLJ10540 and Modulates Migration and Invasion of Lung Cancer via PI3K/AKT Pathway
por: Chen, Chang-Han, et al.
Publicado: (2009)

ARHGAP42 promotes cell migration and invasion involving PI3K/Akt signaling pathway in nasopharyngeal carcinoma
por: Hu, Qian, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ccmr2bfd0ptmjsdoirhda90553